[
    [
        {
            "time": "",
            "original_text": "上海医药(02607.HK)：盐酸多巴胺注射液及盐酸利多卡因注射液通过仿制药一致性评价",
            "features": {
                "keywords": [
                    "上海医药",
                    "盐酸多巴胺注射液",
                    "盐酸利多卡因注射液",
                    "仿制药一致性评价"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "上海医药(02607.HK)：盐酸多巴胺注射液及盐酸利多卡因注射液通过仿制药一致性评价",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "9月17日下午",
            "original_text": "上海医药：拟于9月17日下午举行中报业绩说明会",
            "features": {
                "keywords": [
                    "上海医药",
                    "中报业绩说明会"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "上海医药：拟于9月17日下午举行中报业绩说明会",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "上海医药：枸橼酸咖啡因注射液获得批准生产",
            "features": {
                "keywords": [
                    "上海医药",
                    "枸橼酸咖啡因注射液",
                    "批准生产"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "上海医药：枸橼酸咖啡因注射液获得批准生产",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]